KRAS and malignant colon neoplasm: This enzyme, being the only E2 enzyme, is seen to be sufficient to regulate the overall SUMO status as seen in many instances including a mutant cell model of colon cancer, brain astrocytes, KRAS and invasion of colonic cells by gut pathogens like Salmonella and others [8,31–34].